Related Experiment Video
Updated: May 5, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
17.3K
Angiotensin II type-2 receptor-specific effects on the cardiovascular system
Ying Li1, Xiao-Hui Li, Hong Yuan
1Center of Clinical Pharmacology, third Xiangya hospital, Central South University, Changsha 410013, China;
Cardiovascular Diagnosis and Therapy
|November 28, 2013
Summary
The angiotensin II type-2 receptor (AT2R) plays a crucial role in cardiovascular health. Understanding AT2R regulation is vital for managing blood pressure and heart conditions.
Area of Science:
- Cardiovascular Physiology
- Renal Physiology
Background:
- The renin-angiotensin system (RAS) is central to cardiovascular homeostasis.
- Angiotensin II, via AT1R activation, drives cardiovascular pathologies.
- The function of the angiotensin II type-2 receptor (AT2R) remains less understood.
Purpose of the Study:
- To elucidate the role of AT2R in cardiovascular function.
- To investigate AT2R's involvement in both normal and pathological cardiovascular states.
Main Methods:
- Review of recent studies on AT2R.
- Analysis of AT2R's impact on cardiovascular parameters.
Main Results:
- AT2R significantly influences blood pressure regulation.
- AT2R plays a role in cardiac hypertrophy and fibrosis.
- AT2R impacts myocardial infarction outcomes and vascular homeostasis.
Conclusions:
- AT2R is a key regulator of cardiovascular function.
- Further research into AT2R mechanisms is warranted for therapeutic strategies.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
01:29Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
01:17Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K